Chromoblastomycosis: clinical experience and review of literature
Background Chromoblastomycosis is a tropical chronic infectious dermatosis characterized by the moriform bodies. To review all cases of chromoblastomycosis attended in the reference service of dermatology. Methods Series of cases of chromoblastomycosis attended in a dermatology reference service. Th...
Gespeichert in:
| Veröffentlicht in: | International journal of dermatology 2018-11, Vol.57 (11), p.1351-1355 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1355 |
|---|---|
| container_issue | 11 |
| container_start_page | 1351 |
| container_title | International journal of dermatology |
| container_volume | 57 |
| creator | Queiróz, Amadeu J. R. Pereira Domingos, Fernanda Antônio, João R. |
| description | Background
Chromoblastomycosis is a tropical chronic infectious dermatosis characterized by the moriform bodies. To review all cases of chromoblastomycosis attended in the reference service of dermatology.
Methods
Series of cases of chromoblastomycosis attended in a dermatology reference service. Through an integrated system search of assistance, based on CID‐10 B43, we reviewed epidemiological and comorbidities data, clinical presentations, treatments, and outcomes of each clinical case.
Results
From 2011 to 2017, we had five new cases of chromoblastomycosis. The average age was 65.6 years. All of them were men. One patient was HIV‐positive, and another patient was immunosuppressed by the use of mycophenolate mofetil and prednisone due to renal transplant. Two patients had no history of evident trauma. The time between onset of symptoms and diagnosis ranged from 7 to 600 months. Fonsecaea pedrosoi was the isolated fungi. All cases were formally confirmed. Itraconazole with or without other therapies was effective in all cases.
Conclusions
We report five never reported cases of chromoblastomycosis, and we review the clinical experience in diagnosis and treatment of chromoblastomycosis, an infrequent and neglected subcutaneous mycosis. |
| doi_str_mv | 10.1111/ijd.14185 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2089292215</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2115999255</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3535-19d88b385cda0166c1db697ce01ff5869e30e8bf81a1fee7c9ddfb5f2d26c2463</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMoun4c_ANS8KKHaibZdBtvsn4jeNFzSJMJZmmbNdmq---NrnoQnMswzMPLzEPIPtATyHXqZ_YExlCLNTICXolyXHG2TkaUApSSCrlFtlOa5ZEzGG-SLZ4XnE7YiJxPn2PoQtPqtAjd0oTk01lhWt97o9sC3-cYPfYGC93bIuKrx7ciuKL1C4x6MUTcJRtOtwn3vvsOebq6fJzelPcP17fT8_vScMFFCdLWdcNrYaymUFUGbFPJiUEKzom6ksgp1o2rQYNDnBhprWuEY5ZVhuWHdsjRKncew8uAaaE6nwy2re4xDEkxWksmGQOR0cM_6CwMsc_XKQYgpJRMfFLHK8rEkFJEp-bRdzouFVD16VVlr-rLa2YPvhOHpkP7S_6IzMDpCnjzLS7_T1K3dxeryA_T2oE8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2115999255</pqid></control><display><type>article</type><title>Chromoblastomycosis: clinical experience and review of literature</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Queiróz, Amadeu J. R. ; Pereira Domingos, Fernanda ; Antônio, João R.</creator><creatorcontrib>Queiróz, Amadeu J. R. ; Pereira Domingos, Fernanda ; Antônio, João R.</creatorcontrib><description>Background
Chromoblastomycosis is a tropical chronic infectious dermatosis characterized by the moriform bodies. To review all cases of chromoblastomycosis attended in the reference service of dermatology.
Methods
Series of cases of chromoblastomycosis attended in a dermatology reference service. Through an integrated system search of assistance, based on CID‐10 B43, we reviewed epidemiological and comorbidities data, clinical presentations, treatments, and outcomes of each clinical case.
Results
From 2011 to 2017, we had five new cases of chromoblastomycosis. The average age was 65.6 years. All of them were men. One patient was HIV‐positive, and another patient was immunosuppressed by the use of mycophenolate mofetil and prednisone due to renal transplant. Two patients had no history of evident trauma. The time between onset of symptoms and diagnosis ranged from 7 to 600 months. Fonsecaea pedrosoi was the isolated fungi. All cases were formally confirmed. Itraconazole with or without other therapies was effective in all cases.
Conclusions
We report five never reported cases of chromoblastomycosis, and we review the clinical experience in diagnosis and treatment of chromoblastomycosis, an infrequent and neglected subcutaneous mycosis.</description><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.14185</identifier><identifier>PMID: 30113072</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Aged ; Antifungal Agents - therapeutic use ; Ascomycota ; Chromoblastomycosis - diagnosis ; Chromoblastomycosis - drug therapy ; Chromoblastomycosis - microbiology ; Chromoblastomycosis - pathology ; Chromomycosis ; Delayed Diagnosis ; Dermatology ; Diagnosis ; Epidemiology ; Fungi ; HIV ; Human immunodeficiency virus ; Humans ; Itraconazole ; Itraconazole - therapeutic use ; Kidney transplantation ; Literature reviews ; Male ; Middle Aged ; Mycophenolate mofetil ; Mycophenolic acid ; Mycosis ; Patients ; Prednisone ; Reference services ; Trauma</subject><ispartof>International journal of dermatology, 2018-11, Vol.57 (11), p.1351-1355</ispartof><rights>2018</rights><rights>2018 The International Society of Dermatology.</rights><rights>International Journal of Dermatology © 2018 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3535-19d88b385cda0166c1db697ce01ff5869e30e8bf81a1fee7c9ddfb5f2d26c2463</citedby><cites>FETCH-LOGICAL-c3535-19d88b385cda0166c1db697ce01ff5869e30e8bf81a1fee7c9ddfb5f2d26c2463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijd.14185$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijd.14185$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30113072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Queiróz, Amadeu J. R.</creatorcontrib><creatorcontrib>Pereira Domingos, Fernanda</creatorcontrib><creatorcontrib>Antônio, João R.</creatorcontrib><title>Chromoblastomycosis: clinical experience and review of literature</title><title>International journal of dermatology</title><addtitle>Int J Dermatol</addtitle><description>Background
Chromoblastomycosis is a tropical chronic infectious dermatosis characterized by the moriform bodies. To review all cases of chromoblastomycosis attended in the reference service of dermatology.
Methods
Series of cases of chromoblastomycosis attended in a dermatology reference service. Through an integrated system search of assistance, based on CID‐10 B43, we reviewed epidemiological and comorbidities data, clinical presentations, treatments, and outcomes of each clinical case.
Results
From 2011 to 2017, we had five new cases of chromoblastomycosis. The average age was 65.6 years. All of them were men. One patient was HIV‐positive, and another patient was immunosuppressed by the use of mycophenolate mofetil and prednisone due to renal transplant. Two patients had no history of evident trauma. The time between onset of symptoms and diagnosis ranged from 7 to 600 months. Fonsecaea pedrosoi was the isolated fungi. All cases were formally confirmed. Itraconazole with or without other therapies was effective in all cases.
Conclusions
We report five never reported cases of chromoblastomycosis, and we review the clinical experience in diagnosis and treatment of chromoblastomycosis, an infrequent and neglected subcutaneous mycosis.</description><subject>Aged</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Ascomycota</subject><subject>Chromoblastomycosis - diagnosis</subject><subject>Chromoblastomycosis - drug therapy</subject><subject>Chromoblastomycosis - microbiology</subject><subject>Chromoblastomycosis - pathology</subject><subject>Chromomycosis</subject><subject>Delayed Diagnosis</subject><subject>Dermatology</subject><subject>Diagnosis</subject><subject>Epidemiology</subject><subject>Fungi</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Itraconazole</subject><subject>Itraconazole - therapeutic use</subject><subject>Kidney transplantation</subject><subject>Literature reviews</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mycophenolate mofetil</subject><subject>Mycophenolic acid</subject><subject>Mycosis</subject><subject>Patients</subject><subject>Prednisone</subject><subject>Reference services</subject><subject>Trauma</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1LxDAQhoMoun4c_ANS8KKHaibZdBtvsn4jeNFzSJMJZmmbNdmq---NrnoQnMswzMPLzEPIPtATyHXqZ_YExlCLNTICXolyXHG2TkaUApSSCrlFtlOa5ZEzGG-SLZ4XnE7YiJxPn2PoQtPqtAjd0oTk01lhWt97o9sC3-cYPfYGC93bIuKrx7ciuKL1C4x6MUTcJRtOtwn3vvsOebq6fJzelPcP17fT8_vScMFFCdLWdcNrYaymUFUGbFPJiUEKzom6ksgp1o2rQYNDnBhprWuEY5ZVhuWHdsjRKncew8uAaaE6nwy2re4xDEkxWksmGQOR0cM_6CwMsc_XKQYgpJRMfFLHK8rEkFJEp-bRdzouFVD16VVlr-rLa2YPvhOHpkP7S_6IzMDpCnjzLS7_T1K3dxeryA_T2oE8</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Queiróz, Amadeu J. R.</creator><creator>Pereira Domingos, Fernanda</creator><creator>Antônio, João R.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>201811</creationdate><title>Chromoblastomycosis: clinical experience and review of literature</title><author>Queiróz, Amadeu J. R. ; Pereira Domingos, Fernanda ; Antônio, João R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3535-19d88b385cda0166c1db697ce01ff5869e30e8bf81a1fee7c9ddfb5f2d26c2463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Ascomycota</topic><topic>Chromoblastomycosis - diagnosis</topic><topic>Chromoblastomycosis - drug therapy</topic><topic>Chromoblastomycosis - microbiology</topic><topic>Chromoblastomycosis - pathology</topic><topic>Chromomycosis</topic><topic>Delayed Diagnosis</topic><topic>Dermatology</topic><topic>Diagnosis</topic><topic>Epidemiology</topic><topic>Fungi</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Itraconazole</topic><topic>Itraconazole - therapeutic use</topic><topic>Kidney transplantation</topic><topic>Literature reviews</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mycophenolate mofetil</topic><topic>Mycophenolic acid</topic><topic>Mycosis</topic><topic>Patients</topic><topic>Prednisone</topic><topic>Reference services</topic><topic>Trauma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Queiróz, Amadeu J. R.</creatorcontrib><creatorcontrib>Pereira Domingos, Fernanda</creatorcontrib><creatorcontrib>Antônio, João R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Queiróz, Amadeu J. R.</au><au>Pereira Domingos, Fernanda</au><au>Antônio, João R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chromoblastomycosis: clinical experience and review of literature</atitle><jtitle>International journal of dermatology</jtitle><addtitle>Int J Dermatol</addtitle><date>2018-11</date><risdate>2018</risdate><volume>57</volume><issue>11</issue><spage>1351</spage><epage>1355</epage><pages>1351-1355</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><abstract>Background
Chromoblastomycosis is a tropical chronic infectious dermatosis characterized by the moriform bodies. To review all cases of chromoblastomycosis attended in the reference service of dermatology.
Methods
Series of cases of chromoblastomycosis attended in a dermatology reference service. Through an integrated system search of assistance, based on CID‐10 B43, we reviewed epidemiological and comorbidities data, clinical presentations, treatments, and outcomes of each clinical case.
Results
From 2011 to 2017, we had five new cases of chromoblastomycosis. The average age was 65.6 years. All of them were men. One patient was HIV‐positive, and another patient was immunosuppressed by the use of mycophenolate mofetil and prednisone due to renal transplant. Two patients had no history of evident trauma. The time between onset of symptoms and diagnosis ranged from 7 to 600 months. Fonsecaea pedrosoi was the isolated fungi. All cases were formally confirmed. Itraconazole with or without other therapies was effective in all cases.
Conclusions
We report five never reported cases of chromoblastomycosis, and we review the clinical experience in diagnosis and treatment of chromoblastomycosis, an infrequent and neglected subcutaneous mycosis.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>30113072</pmid><doi>10.1111/ijd.14185</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0011-9059 |
| ispartof | International journal of dermatology, 2018-11, Vol.57 (11), p.1351-1355 |
| issn | 0011-9059 1365-4632 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2089292215 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Aged Antifungal Agents - therapeutic use Ascomycota Chromoblastomycosis - diagnosis Chromoblastomycosis - drug therapy Chromoblastomycosis - microbiology Chromoblastomycosis - pathology Chromomycosis Delayed Diagnosis Dermatology Diagnosis Epidemiology Fungi HIV Human immunodeficiency virus Humans Itraconazole Itraconazole - therapeutic use Kidney transplantation Literature reviews Male Middle Aged Mycophenolate mofetil Mycophenolic acid Mycosis Patients Prednisone Reference services Trauma |
| title | Chromoblastomycosis: clinical experience and review of literature |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A47%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chromoblastomycosis:%20clinical%20experience%20and%20review%20of%20literature&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Queir%C3%B3z,%20Amadeu%20J.%20R.&rft.date=2018-11&rft.volume=57&rft.issue=11&rft.spage=1351&rft.epage=1355&rft.pages=1351-1355&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.14185&rft_dat=%3Cproquest_cross%3E2115999255%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2115999255&rft_id=info:pmid/30113072&rfr_iscdi=true |